Alexander L Rakhmilevich

7PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 25, 2025
Immune-mediated Engagement of T Regulatory Cells with Tumor Cells Results in Trogocytosis and Tumor Cell Killing.

Amy K Erbe, Arika S Feils, Anqi Gao

|Nov 24, 2025
Divergent role of CD8 T cells with distinct metabolic phenotypes during curative radio-immunotherapy in hot versus cold tumors.

Alexa R Heaton, Nathaniel J Burkard, Anqi Gao

|Nov 01, 2025
High-risk neuroblastoma as a model for immunotherapy of non-immunogenic cancers: where might we be in 20 years?

Paul M Sondel, Alexander L Rakhmilevich, Israrul H Ansari

|Apr 04, 2023
Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist.

Alexander A Pieper, Dan V Spiegelman, Mildred A R Felder

|Jan 13, 2023
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination.

Peter M Carlson, Ravi B Patel, Jen Birstler

|May 26, 2022
Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma.

Taylor J Aiken, Amy K Erbe, Lauren Zebertavage

Pageof 2

Frequent Collaborators

6 joint publications

Paul M Sondel

4 joint publications

Amy K Erbe

3 joint publications

Arika S Feils

3 joint publications

Noah W Tsarovsky